Literature DB >> 19458347

Association of fluconazole pharmacodynamics with mortality in patients with candidemia.

Maiken C Arendrup, Manuel Cuenca-Estrella, J Peter Donnelly, Cornelia Lass-Flörl, Juan L Rodriguez-Tudela.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19458347      PMCID： PMC2687210          DOI： 10.1128/AAC.01411-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  11 in total

1.  Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method.

Authors:  Luis Ostrosky-Zeichner; John H Rex; Michael A Pfaller; Daniel J Diekema; Barbara D Alexander; David Andes; Steven D Brown; Vishnu Chaturvedi; Mahmoud A Ghannoum; Cindy C Knapp; Daniel J Sheehan; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

2.  Clinical correlates of antifungal macrodilution susceptibility test results for non-AIDS patients with severe Candida infections treated with fluconazole.

Authors:  S C Lee; C P Fung; J S Huang; C J Tsai; K S Chen; H Y Chen; N Lee; L C See; W B Shieh
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

Review 3.  Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards.

Authors:  J H Rex; M A Pfaller; J N Galgiani; M S Bartlett; A Espinel-Ingroff; M A Ghannoum; M Lancaster; F C Odds; M G Rinaldi; T J Walsh; A L Barry
Journal:  Clin Infect Dis       Date:  1997-02       Impact factor: 9.079

4.  Pharmacodynamics of fluconazole in a murine model of systemic candidiasis.

Authors:  A Louie; G L Drusano; P Banerjee; Q F Liu; W Liu; P Kaw; M Shayegani; H Taber; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

5.  Fluconazole MIC and the fluconazole dose/MIC ratio correlate with therapeutic response among patients with candidemia.

Authors:  Cornelius J Clancy; Victor L Yu; Arthur J Morris; David R Snydman; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

6.  In vivo pathogenicity of eight medically relevant Candida species in an animal model.

Authors:  M Arendrup; T Horn; N Frimodt-Møller
Journal:  Infection       Date:  2002-10       Impact factor: 3.553

7.  Characterization and quantitation of the pharmacodynamics of fluconazole in a neutropenic murine disseminated candidiasis infection model.

Authors:  D Andes; M van Ogtrop
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

8.  Association of fluconazole area under the concentration-time curve/MIC and dose/MIC ratios with mortality in nonneutropenic patients with candidemia.

Authors:  Manjunath P Pai; Robin S Turpin; Kevin W Garey
Journal:  Antimicrob Agents Chemother       Date:  2006-11-13       Impact factor: 5.191

9.  Association of fluconazole pharmacodynamics with mortality in patients with candidemia.

Authors:  John W Baddley; Mukesh Patel; Sujata M Bhavnani; Stephen A Moser; David R Andes
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

10.  Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia.

Authors:  Juan L Rodríguez-Tudela; Benito Almirante; Dolors Rodríguez-Pardo; Fernando Laguna; J Peter Donnelly; Johan W Mouton; Albert Pahissa; Manuel Cuenca-Estrella
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191
View more
  3 in total

1.  In Vivo Microdialysis To Determine Subcutaneous Interstitial Fluid Penetration and Pharmacokinetics of Fluconazole in Intensive Care Unit Patients with Sepsis.

Authors:  Mahipal G Sinnollareddy; Michael S Roberts; Jeffrey Lipman; Melissa Lassig-Smith; Therese Starr; Thomas Robertson; Sandra L Peake; Jason A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2015-11-23       Impact factor: 5.191

Review 2.  Epidemiology and antifungal resistance in invasive candidiasis.

Authors:  C Rodloff; D Koch; R Schaumann
Journal:  Eur J Med Res       Date:  2011-04-28       Impact factor: 2.175

3.  Characteristics of hospital-acquired and community-onset blood stream infections, South-East Austria.

Authors:  Martin Hoenigl; Jasmin Wagner; Reinhard B Raggam; Florian Prueller; Juergen Prattes; Susanne Eigl; Eva Leitner; Katharina Hönigl; Thomas Valentin; Ines Zollner-Schwetz; Andrea J Grisold; Robert Krause
Journal:  PLoS One       Date:  2014-08-08       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.